Have you got a receipt for those? Next CEO in share disposal
5th Apr 2012 15:31
Lord Wolfson of Aspley Guise, Chief Executive of High Street retailer Next, has made his first sale since March 2007 in a move which triggered a widespread sale of the company's shares. Wolfson, who has stood at the helm of the chain store since 2001, sold off 125,000 shares at 3,057p each for a t
Read moreStorm of activity at Summit as fund raising announced
4th Apr 2012 10:01
It's all go at Oxford based drug developer Summit Corporation as the firm announces a five million pound share placing, appoints a new Chief Executive and reveals encouraging results for an anti-superbug drug. The company says it will issue 166,666,670 new shares at 3p per share to "certain institu
Read moreSmall caps round up: Summit Corp, Jubilant Energy, Solo Oil...
6th Mar 2012 14:37
Summit Corporation, a drug research group, has reported positive data from in vivo studies in its drug discovery programme targeting Alzheimer's disease and related neurodegenerative disorders. The most recent tril has discoved a way to enable the drug to penetrate the Blood Brain Barrier and enter
Read moreSummit platform attracts interest
30th Mar 2011 16:31
Drug discovery company Summit Corporation is in discussions with potential partners for the Seglin platform. The Seglin platform enables the identification of mew treatments. The platform is being used to identify cancer and metabolic diseases treatments. AIM-quoted Summit suffered a operating c
Read morePositive trial results for Summit drug
14th Mar 2011 12:25
AIM-quoted Summit Corporation has revealed positive non-clinical efficacy results for SMT C1100, a treatment for Duchenne muscular dystrophy (DMD). The Summit share price rose by nearly one-fifth following the announcement. DMD is caused by the loss of a protein called dystrophin which results in
Read morePositive results for Summit's superbug treatment
12th Oct 2010 15:31
Drug discoverer Summit Corporation says that trials of its SMT 19969 C. difficile treatment show that it is superior to existing treatments. Summit has the backing of the Wellcome Trust, which is funding the programme. SMT 19969 provides protection from initial and recurring infections. There is
Read moreXP Power founder trims holding
4th Aug 2010 16:28
XP Power deputy chairman James Peters raised £1.47m from a share disposal two days after bumper interim figures from the power control products supplier. Peters sold 200,000 shares at 735p each. Peters founded XP in 1988 and still owns nearly 2.7m shares, which is equivalent to 14%. That still mak
Read moreSmall caps round-up: Devro, Catalytic Solutions, Summit
3rd Aug 2010 16:26
Sausage casings manufacturer Devro reported a sharp rise in interim profit and a 40% increase in its interim dividend to 2p a share. Pre-exceptional profit was 86% ahead at £17.1m as sales increased 11% to £116.1m in the six months to June 2010. The market for collagen casings is growing at 5% a y
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
8th Jul 2010 09:48
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0848 GMT [Dow Jones] Singer Capital Markets initiates coverage of Summit Corp. (SUMM.LN) with an 11p price target. The broker
Read moreMARKET TALK: Singer Initiates Summit Corp. With 11p Target
8th Jul 2010 09:48
0848 GMT [Dow Jones] Singer Capital Markets initiates coverage of Summit Corp. (SUMM.LN) with an 11p price target. The broker says the drug development and research services firm has a promising therapy for Duchenne muscular dystrophy in early-stage clinical trials with BioMarin (BMRN), as well as a
Read moreSummit Corporation Sees Opportunities For Partner Funded Programs
17th Jun 2010 07:37
LONDON (Dow Jones)--Summit Corporation PLC (SUMM.LN), a U.K. based drug discovery company, said Thursday it has a number of opportunities to deliver commercial success from its portfolio of partner funded programs and Seglin technology platform, adding that it is currently exploring potential collab
Read moreSmall caps round-up: Tower Resources, Global Petroleum, Norseman Gold
24th Feb 2010 09:44
Shares in Global Petroleum and Tower Resources slumped after the companies reported that the Avivi-1 well in Uganda had reached its total depth without showing any oil. Avivi-1 is owned by Tower, while Global has an option to earn a 25% interest in the licence, by funding 25% of the costs. 'Electr
Read moreNew Travis chairman buys
30th Oct 2009 16:31
Robert Walker, the chairman-designate of Travis Perkins, has bought his first shares in the builders' merchant. Walker was appointed to the Travis Perkins board on 30 September 2009 and he is due to take over as chairman from Tim Stevenson in May 2010. Walker has bought a total of 25,000 shares at
Read more